Sequence:

References:

• Wu M,Hancock RE
  J Biol Chem, 1999, 29-35
  
  
  Interaction of the cyclic antimicrobial cationic peptide bactenecin with the outer and cytoplasmic membrane.
  
• Hancock RE,Yan H
  Antimicrob Agents Chemother, 2001, 1558-1560
  
  
  Synergistic interactions between mammalian antimicrobial defense peptides.
  
• Hancock RE,Wu M
  Antimicrob Agents Chemother, 1999, 1274-1276
  
  
  Improved derivatives of bactenecin, a cyclic dodecameric antimicrobial cationic peptide.
  
• Vila-Farres X,Garcia de la Maria C,López-Rojas R,Pachón J,Giralt E,Vila J
  Clin Microbiol Infect, 2012, 383-387
  
  
  In vitro activity of several antimicrobial peptides against colistin-susceptible and colistin-resistant Acinetobacter baumannii.
  
• Lee JY,Yang ST,Lee SK,Jung HH,Shin SY,Hahm KS,Kim JI
  FEBS J, 2008, 3911-3920
  
  
  Salt-resistant homodimeric bactenecin, a cathelicidin-derived antimicrobial peptide.
  
• Portell-Buj E,Vergara A,Alejo I,López-Gavín A,Monté MR,San Nicolás L,González-Martín J,Tudó G
  J Med Microbiol, 2018,
  
  
  In vitro activity of 12 antimicrobial peptides against Mycobacterium tuberculosis and Mycobacterium avium clinical isolates.
  
• Sim JY,Kim S,Lee J,Lim H,Kim HH,Park ZY,Kim JI
  Biochem Biophys Res Commun, 2019,
  
  
  A significantly enhanced antibacterial spectrum of D-enantiomeric lipopeptide bactenecin.